NCT02902016View on ClinicalTrials.gov

Modulation of Lactase Expression by a New PPARgamma Ligand in Duodenal Biopsies

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

July 16, 2015

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Lactose Intolerance
Interventions
DRUG

GED

Four duodenal biopsies will be collected. Two biopsies will stimulated with GED (PPARgamma modulator) ex vivo during 6 hours. Two biopsies will be unstimulated (control).

Trial Locations (1)

Unknown

CHRU, Hôpital Claude Huriez, Lille

All Listed Sponsors
collaborator

French National Society of Gastroenterology

OTHER

collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

University Hospital, Lille

OTHER

NCT02902016 - Modulation of Lactase Expression by a New PPARgamma Ligand in Duodenal Biopsies | Biotech Hunter | Biotech Hunter